|
I.B. Zhurtova, A.M. Gubachikova, L.S. Aramisova, H.A. Abdul Moati, L.A. Anaeva
Metabolic effects of metformin in patients with type 2 diabetes mellitus and new coronavirus infection
|
№12 / 2023
|
|
A.U.k. Kazimova, Sh.M.k. Polukhova
Pharmacotherapeutic aspects of gestational diabetes mellitus against the background of impaired maternal immunity
|
№4-5 / 2023
|
|
S.V. Podachina, E.V. Biryukova, I.V. Solovievа
Combination therapy for type 2 diabetes maintains its position. Clinical case
|
№3 / 2023
|
|
N.A. Petunina, N.S. Martirosyan, F.V. Valeeva
Cardiovascular outcomes during treatment with dipeptidyl peptidase-4 inhibitors depending on renal function and combination with metformin: a systematic review
|
№11-12 / 2022
|
|
A.E. Bagriy, O.A. Prikolota, A.V. Prikolota, E.S. Mikhailichenko, I.A. Golodnikov, O.N. Bagriy, K.A. Kotova
Clinical effects of dapagliflozin in patients with type 2 diabetes mellitus and paroxysmal atrial fibrillation
|
№11-12 / 2022
|
|
L.Yu. Morgunov
Type 3 diabetes mellitus: is there a chance to become famous?
|
№4 / 2022
|
|
P.B. Shorokhova, V.L. Baranov
Differentiated approach to metformin therapy in newly diagnosed type 2 diabetes mellitus from the perspective of pharmacogenetics
|
№12 / 2021
|
|
A.F. Verbovoy, Yu.A. Dolgikh
Insulin resistance – a common enemy for endocrinologists and cardiologists
|
№12 / 2021
|
|
E.V. Biryukova, I.V. Solovyova
Do we know everything about the possibilities of metformin in the treatment of type 2 diabetes mellitus? Which of its combinations is the most studied, effective and available for the patient in the real practice of the endocrinologist?
|
№4 / 2019
|
|
M.B. Antsiferov (1), V.V. Fadeev (2), T.B. Morgunova (2)
MODERN APPROACHES TO THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS
|
№16 / 2016
|
|
M.B. Antsiferov
APPLICATION OF SAXAGLIPTIN AND ITS COMBINATION WITH METFORMIN IN THE THERAPY OF TYPE 2 DIABETES MELLITUS IN ELDERLY PATIENTS
|
№5 / 2016
|
|
M.B. Antsiferov (1), T.P. Nikitina (2), A.Yu. Rodionova (3), K.A. Kurbatova (2), T.I. Ionova (2)
HYPOGLYCEMIA AND QUALITY OF LIFE OF PATIENTS WITH TYPE 2 DIABETES MELLITUS
|
№17 / 2015
|
Русский
